Next Article in Journal
First Total Synthesis of Ergosta-5,8-dien-3β-ol Erste Totalsynthese von Ergosta-5,8-dien-3β-ol
Previous Article in Journal
Instructions for Authors 2008
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cyclodextrins as Drug Carrier Molecule: A Review

by
ARUN RASHEED
*,
ASHOK KUMAR C. K.
and
SRAVANTHI V. V. N. S. S.
Department of Pharmaceutical Chemistry, Sree Vidyanikethan College of Pharmacy, Sri Sainath Nagar, Tirupati, Andhra Pradesh 517502, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2008, 76(4), 567-598; https://doi.org/10.3797/scipharm.0808-05
Submission received: 5 August 2008 / Accepted: 31 October 2008 / Published: 1 November 2008

Abstract

The cyclodextrins have a wide range of applications in different areas of drug delivery and pharmaceutical industry due to their complexation ability and other versatile characteristics. The most common pharmaceutical application of cyclodextrin is to enhance the solubility, stability, safety and bioavailability of drug molecules. The purpose of this review is to discuss and summarize some of the findings and applications of cyclodextrin (CD) and their derivatives in different areas of drug delivery. This article highlights the molecular structure, properties like complexation, solubility etc. of cyclodextrins and focuses on its use for parenteral, oral, ophthalmic and nasal drug delivery. Other routes including dermal, rectal, sublingual and pulmonary delivery are also briefly addressed. The objective of this contribution is to focus on the potential use of chemically modified cyclodextrins as high-performance drug carriers in drug delivery systems with emphasis on the more recent developments. Thus cyclodextrins, because of their continuing ability to find several novel applications in drug delivery, are expected to solve many problems associated with the delivery of different novel drugs through different delivery routes.
Keywords: Cyclodextrins; Drug formulation; Drug delivery; Complexation; Novel delivery systems Cyclodextrins; Drug formulation; Drug delivery; Complexation; Novel delivery systems

Share and Cite

MDPI and ACS Style

RASHEED, A.; K., A.K.C.; S., S.V.V.N.S. Cyclodextrins as Drug Carrier Molecule: A Review. Sci. Pharm. 2008, 76, 567-598. https://doi.org/10.3797/scipharm.0808-05

AMA Style

RASHEED A, K. AKC, S. SVVNS. Cyclodextrins as Drug Carrier Molecule: A Review. Scientia Pharmaceutica. 2008; 76(4):567-598. https://doi.org/10.3797/scipharm.0808-05

Chicago/Turabian Style

RASHEED, ARUN, ASHOK KUMAR C. K., and SRAVANTHI V. V. N. S. S. 2008. "Cyclodextrins as Drug Carrier Molecule: A Review" Scientia Pharmaceutica 76, no. 4: 567-598. https://doi.org/10.3797/scipharm.0808-05

APA Style

RASHEED, A., K., A. K. C., & S., S. V. V. N. S. (2008). Cyclodextrins as Drug Carrier Molecule: A Review. Scientia Pharmaceutica, 76(4), 567-598. https://doi.org/10.3797/scipharm.0808-05

Article Metrics

Back to TopTop